0001096906-24-000511.txt : 20240319 0001096906-24-000511.hdr.sgml : 20240319 20240319191608 ACCESSION NUMBER: 0001096906-24-000511 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240315 FILED AS OF DATE: 20240319 DATE AS OF CHANGE: 20240319 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MALASEK ROBERT CENTRAL INDEX KEY: 0001493185 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-54296 FILM NUMBER: 24765712 MAIL ADDRESS: STREET 1: PO BOX 235472 CITY: ENCINITAS STATE: CA ZIP: 92023 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AXIM BIOTECHNOLOGIES, INC. CENTRAL INDEX KEY: 0001514946 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 274092986 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6191 CORNERSTONE COURT, E STREET 2: SUITE 114 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: (212) 751-0001 MAIL ADDRESS: STREET 1: 6191 CORNERSTONE COURT, E STREET 2: SUITE 114 CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: AXIM INTERNATIONAL INC. DATE OF NAME CHANGE: 20110309 4 1 form4.xml PRIMARY DOCUMENT X0508 4 2024-03-15 0 0001514946 AXIM BIOTECHNOLOGIES, INC. AXIM 0001493185 MALASEK ROBERT 6191 CORNERSTONE COURT, E. SUITE 114 SAN DIEGO CA 92121 0 1 0 0 Chief Financial Officer 0 Convertible Note 0.0200 2024-03-15 4 A 0 53500.0000 53500.0000 A 2024-03-15 2034-03-01 Common Stock 2675000.0000 3475000.0000 D Reporting Person acquired a Convertible Note face $53,500. The Note is convertible into shares of the Issuers common stock at a price of $0.02 per share. /s/ Robert Malasek 2024-03-18